Susan Bryce v. HHS - Influenza, idiopathic thrombocytopenia (ITP) and residual mononeuropathy (2023)

Susan Bryce filed a petition on January 30, 2017, alleging that she developed idiopathic thrombocytopenia (ITP) and residual mononeuropathy as a result of an influenza vaccine received on December 18, 2016. This decision addresses her motion for interim attorneys' fees and costs.

The court found that the petitioner had filed her petition in good faith and with a reasonable basis, supported by expert reports from a hematologist and a neurologist. The court also determined that the petitioner would suffer undue hardship without an award of interim fees and costs due to the protracted nature of the proceedings and the retention of costly experts.

The court awarded a total of $58,305.27 in interim attorneys' fees and costs, jointly payable to Susan Bryce and her attorney, Mark Sadaka. The award included attorneys' fees and costs for medical records, filing fees, expert fees, and mailing expenses, with a minor reduction for clerical tasks.